Gene · 4174
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway. | Oncol Lett | 2023 | 37153049 | PubTator, text mining | PubMed |
| The assembly of the MCM2-7 hetero-hexamer and its significance in DNA replication. | Biochem Soc Trans | 2023 | 37145026 | PubTator, text mining | PubMed |
| Mutational analysis of minichromosome maintenance complex component (MCM) family genes in Chinese Han women with polycystic ovarian syndrome. | Gynecol Endocrinol | 2023 | 37132453 | PubTator, text mining | PubMed |
| Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex. | iScience | 2023 | 37123243 | PubTator, text mining | PubMed |
| Proteasome inhibitor MG132 enhances the sensitivity of human OSCC cells to cisplatin via a ROS/DNA damage/p53 axis. | Exp Ther Med | 2023 | 37123203 | PubTator, text mining | PubMed |
| Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis. | Proteins | 2023 | 37119038 | PubTator, text mining | PubMed |
| Finding New Molecular Targets of Two Copper(II)-Hydrazone Complexes on Triple-Negative Breast Cancer Cells Using Mass-Spectrometry-Based Quantitative Proteomics. | Int J Mol Sci | 2023 | 37108690 | PubTator, text mining | PubMed |
| Secretome Screening of BRAFV600E-Mutated Colon Cancer Cells Resistant to Vemurafenib. | Biology (Basel) | 2023 | 37106808 | PubTator, text mining | PubMed |
| Identification of p53-target genes in human papillomavirus-associated head and neck cancer by integrative bioinformatics analysis. | Front Oncol | 2023 | 37081989 | PubTator, text mining | PubMed |
| WHSC1 is involved in DNA damage, cellular senescence and immune response in hepatocellular carcinoma progression. | J Cell Mol Med | 2023 | 37073435 | PubTator, text mining | PubMed |
| The expanding genetic and clinical landscape associated with Meier-Gorlin syndrome. | Eur J Hum Genet | 2023 | 37059840 | PubTator, text mining | PubMed |
| Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer. | Cancer Cell | 2023 | 37059104 | PubTator, text mining | PubMed |
| Current Knowledge about the Impact of Microgravity on Gene Regulation. | Cells | 2023 | 37048115 | PubTator, text mining | PubMed |
| Understanding cell fate acquisition in stem-cell-derived pancreatic islets using single-cell multiome-inferred regulomes. | Dev Cell | 2023 | 37040771 | PubTator, text mining | PubMed |
| Spatiotemporally resolved transcriptomics reveals the subcellular RNA kinetic landscape. | Nat Methods | 2023 | 37038000 | PubTator, text mining | PubMed |
| Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway. | Oncogene | 2023 | 37029300 | PubTator, text mining | PubMed |
| Reducing MYC's transcriptional footprint unveils a good prognostic gene signature in melanoma. | Genes Dev | 2023 | 37024284 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Hypoxia-mediated regulation of DDX5 through decreased chromatin accessibility and post-translational targeting restricts R-loop accumulation. | Mol Oncol | 2023 | 37013907 | PubTator, text mining | PubMed |
| Exogenous hydrogen sulfide (H2S) exerts therapeutic potential in triple-negative breast cancer by affecting cell cycle and DNA replication pathway. | Biomed Pharmacother | 2023 | 37002576 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4174/papers?page=9